Rishi Kakar
Psychiatry · Tamarac, FLNPI 1184821928
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $72,576 of the $93,606 with a category attached, or 77.5%. 11 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 59.7% of the total. Reporting peaked in 2019 at $54,588 and has fallen 92.9% since, to $3,897 in 2025. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $673.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$56K
- Johnson & Johnson$21K
- Alkermes, Inc.$8K
- E.r. Squibb & Sons, L.L.C.$3K
- F. Hoffmann-la Roche AG$2K
- Neurocrine Biosciences, Inc.$2K
- plus $901 from 5 others
Across 2,828 payments — averaging $8404.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6.5M
- AbbVie$4.3M
- Teva Pharmaceuticals USA, Inc.$3.4M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2.5M
- Vanda Pharmaceuticals Inc.$1.9M
- E.r. Squibb & Sons, L.L.C.$1.2M
- plus $4.1M from 25 others
What the payments were for
- Consulting fees$12,01313%
- Speaking & faculty fees$72,57678%
- Travel & lodging$5,5196%
- Food & beverage$3,3724%
- Education$1260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 60 | $55,838 |
| Johnson & Johnson | 35 | $21,384 |
| Alkermes, Inc. | 13 | $7,999 |
| E.r. Squibb & Sons, L.L.C. | 5 | $3,457 |
| F. Hoffmann-la Roche AG | 1 | $2,405 |
| Neurocrine Biosciences, Inc. | 11 | $1,623 |
| Sunovion Pharmaceuticals Inc. | 1 | $420 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $175 |
| AbbVie | 6 | $153 |
| Teva Pharmaceuticals USA, Inc. | 5 | $134 |
| Boehringer Ingelheim | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$93,606 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Tamarac
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.